SEC Tracker
Get the app

Kala Bio KALA

KALA BIO, Inc. entered into retention agreements with a number of its employees

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
  • Reports an executive or board change (5.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Kala Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Lexaria Bioscience LEXX public float $25M, Feb 28, 2025, over 18 months old
  2. Aytu Biopharma AYTU public float $24M, Dec 31, 2025
  3. Tenax Therapeutics TENX public float $24M, Jun 30, 2025
  4. Nanoviricides NNVC public float $24M, Dec 31, 2025
  5. Lisata Therapeutics LSTA public float $24M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.